The increase in BIRC6 expression in Gleason 6–8 clinical prostate cancers (Fig. 2E), including castration-resistant cancers (Fig. 2F), suggests an important role for this protein in the development and progression of the disease. This evidence concerns the gene BIRC6 and prostate carcinoma.